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RESEARCH ARTICLE
A preliminary study of movement 
intensity during a Go/No-Go task and its 
association with ADHD outcomes and symptom 
severity
Fenghua Li1,7†, Yi Zheng2†, Stephanie D. Smith3,4, Frederick Shic8, Christina C. Moore3,5, Xixi Zheng6, Yanjie Qi2, 
Zhengkui Liu1* and James F. Leckman3*
Abstract 
Objective: At present, there are no well-validated biomarkers for attention-deficit/hyperactivity disorder (ADHD). The 
present study used an infrared motion tracking system to monitor and record the movement intensity of children and 
to determine its diagnostic precision for ADHD and its possible associations with ratings of ADHD symptom severity.
Methods: A Microsoft motion sensing camera recorded the movement of children during a modified Go/No-Go 
Task. Movement intensity measures extracted from these data included a composite measure of total movement 
intensity (TMI measure) and a movement intensity distribution (MID measure) measure across 15 frequency bands (FB 
measures). In phase 1 of the study, 30 children diagnosed with ADHD or at subthreshold for ADHD and 30 matched 
healthy controls were compared to determine if measures of movement intensity successfully distinguished children 
with ADHD from healthy control children. In phase 2, associations between measures of movement intensity and 
clinician-rated ADHD symptom severity (Clinical Global Impression Scale [CGI] and the ADHD-Rating Scale IV [ADHD-
RS]) were examined in a subset of children with ADHD (n = 14) from the phase I sample.
Results: Both measures of movement intensity were able to distinguish children with ADHD from healthy controls. 
However, only the measures linked to the 15 pre-determined 1 Hz frequency bands were significantly correlated with 
both the CGI scores and ADHD-RS total scores.
Conclusions: Preliminary findings suggest that measures of movement intensity, particularly measures linked to the 
10–11 and 12–13 Hz frequency bands, have the potential to become valid biomarkers for ADHD.
Keywords: ADHD, Infrared motion tracking system, Microsoft Kinect, Movement intensity, Frequency bands, 
Biomarker
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Background
Attention-deficit/hyperactivity disorder (ADHD) is 
a neurodevelopmental disorder, with an estimated 
prevalence rate of 5.3% worldwide [1]. In the diagnostic 
and statistical manual of mental disorders 5th edition 
(DSM 5), ADHD consists of three distinct presentations: 
inattentive type, hyperactive-impulsive type, and com-
bined type [2]. Multiple methods have been used to diag-
nose and assess ADHD and its presentations in children, 
including clinical interviews, symptom rating scales, 
behavioral observations, and neuropsychological assess-
ments. However, some of these methods are quite subjec-
tive as they rely on parent, teacher, and clinician ratings 
of ADHD symptom severity. It has been suggested that 
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relying on only one of these traditional assessment pro-
cedures and not taking a multi-informant, multi-method 
approach while assessing children’s functioning across 
multiple settings, which is currently considered the “gold 
standard” of diagnostic assessment, may contribute to 
the over-labeling of children with ADHD, the global rise 
of ADHD diagnoses in recent years, and the surge in pre-
scribing stimulant medication [3, 4]. However, the sole 
use of ADHD symptom checklists to make diagnostic 
decisions is not surprising given the “gold standard” can 
be both costly and time consuming.
As a result, researchers have become increasingly inter-
ested in identifying objective assessment procedures for 
ADHD that are comparable to the “gold standard” and 
are more likely to put into practice by clinicians. One 
approach that has gained traction in recent years is the 
use of motor tracking systems during neuropsychologi-
cal tasks of attention and response inhibition. Examples 
include the use of infrared motion tracking systems that 
record the vertical and horizontal position of reflectors 
while children complete a continuous performance task 
[5–13], or actigraphs/accelerometers (i.e., an acceleration 
sensor that measures the acceleration of specific body 
regions) that monitor gross motor activity of children by 
having them wear sensors on specified locations of their 
body (e.g., wrist, waist) [14–18]. Martín-Martínez et  al. 
[19] were able to identify children with ADHD combined 
type by means of a nonlinear analysis of 24-h-long acti-
graphic registries. Although this method of classifica-
tion achieved adequate to good precision (Area Under 
receiver operating characteristic Curve [AUC] values 
between 0.812 and 0.891), it required an entire 24-h 
interval of actigraphic data to reach practical diagnos-
tic capabilities. The need for this amount of movement 
data to make accurate diagnostic predictions is perhaps 
not surprising, as the actigraph only captures movement 
as generated by one or two locations on the body rather 
than simultaneously capturing movements of the entire 
body. Although currently available actigraph devices can 
(and do) record temporal or spatial information (e.g., 
[14], this information has typically been lost in prior 
studies of children with ADHD due to the way the data 
were handled and analyzed.
In contrast, infrared motion tracking systems have 
been previously shown to discriminate boys with ADHD 
from healthy controls; to correlate with teachers’ ADHD 
symptom severity ratings and measures of treatment 
response; and to identify medication doses that pro-
duce the best overall clinical results [7, 12, 20, 21]. The 
data acquired from infrared motion tracking systems are 
time-locked and able to record the path of movement 
(i.e., linear versus complex movement patterns); however, 
methods for integrating movement data across sensors 
have yet to be developed or reported (instead data from 
each sensor is reported separately), which potentially 
limits the precision of these data. In fact, a discrimination 
analysis of the complexity of head movements did less 
well in correctly identifying children with ADHD inat-
tentive type from healthy controls (75% of cases correctly 
classified) than it did with other ADHD presentations. 
Moreover, head movement data did not significantly 
correlate with parent ratings of ADHD symptom sever-
ity [9]. At this time, no known studies have examined the 
relationship between body movement data as captured 
by infrared tracking systems and hyperactive/impulsive 
versus inattentive symptoms. If whole body movements 
are simultaneously tracked and integrated, such a meas-
ure may be sensitive enough to align with severity ratings 
of inattention since more movement is expected as atten-
tion diminishes.
The present study is the first to extract movement 
intensity measures from recordings of whole body move-
ments and to examine whether these measures might 
be potential biomarkers for ADHD. A biomarker is a 
directly measurable indicator that may be used to diag-
nose, evaluate, and monitor the course of a disease as 
well as predict treatment response [22, 23]. To achieve 
this goal, movement data tracked and recorded by a 
Microsoft Kinect System during a Go/No-Go task were 
analyzed using state-of-the-art signal processing strate-
gies that made use of all available data. It was expected 
that the Kinect system’s ability to capture and integrate 
whole body movements would increase the precision 
with which children with ADHD are identified and be 
sensitive enough to correlate with symptoms of inatten-
tion and hyperactivity/impulsivity.
Methods
Study design
This was a two-phase cross-sectional study. The first 
phase included both an ADHD and a control group 
to assess the discriminating capabilities of movement 
intensity measures extracted from data collected by a 
Microsoft Kinect System. The second phase of the study 
included only a subset of the ADHD group and was 
designed to explore associations between movement 
intensity measures and ADHD symptomatology.
Participants
Subjects were girls and boys aged 6–12  years living in 
Beijing city. Children in the ADHD group were selected 
to participate if they met diagnostic criteria for any pres-
entation of ADHD (inattentive, hyperactive-impulsive, or 
combined) according to DSM-5 criteria [2] or who were 
considered to be subthreshold for ADHD, defined as one 
symptom short of meeting diagnostic criteria. Children 
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with ADHD were excluded if any other co-morbid psy-
chiatric condition (e.g., anxiety disorder, depression) 
was present. A subset of ADHD cases (N  =  14) were 
recruited from a randomized, wait-list controlled, multi-
site study entitled, the “Integrated Brain, Body and Social 
(IBBS) Intervention for Attention-Deficit/Hyperactivity 
Disorder” (ClinicalTrials.gov Identifier: NCT01542528; 
IBBS study) [24] whereas the rest of the ADHD partici-
pants (N = 16) were outpatients from a psychiatric hos-
pital serving Beijing City. Children in the control group 
were matched to children in the ADHD group according 
to age and gender and were recruited from a local ele-
mentary school.
A total of 60 children were enrolled in phase I of the 
study. Thirty children were in the ADHD group and 30 
children were in the control group. All participants were 
of Han ancestry and each group consisted of 28 boys 
and 2 girls. The mean age for both groups was 8.95 years 
(SD = 1.88). The ADHD group consisted of 19 children 
with ADHD combined type, 5 with inattentive type, 4 
with hyperactive-impulsive type, 1 with subthreshold 
combined type, and 1 with subthreshold inattentive type 
based on in-person clinical evaluations. One child in the 
ADHD group had discontinued treatment with methyl-
phenidate (10 mg) due to side effects for 6 months prior 
to participation in the study.
In phase 2, a total of 14 children from the IBBS study 
with ADHD or subthreshold for ADHD (9 ADHD com-
bined type, 1 inattentive type, 2 hyperactive-impulsive 
type, 1 subthreshold combined type, and 1 subthreshold 
inattentive type) participated. The mean age of the sam-
ple was 7.32 years (SD = 1.02). Except for the one child 
referred to above, all participants were medication naive. 
Considering ADHD symptom severity ratings were com-
pleted only for participants from the IBBS study as part 
of the assessment protocol and not for those partici-
pants recruited from the outpatient clinic, the sample in 
phase II of the study was limited to just the IBBS study 
participants.
Measures
ADHD symptom severity
ADHD symptoms were assessed using the ADHD Rat-
ing Scale IV (ADHD-RS, [25]). The ADHD-RS has been 
used repeatedly in the extant literature as a primary out-
come measure in ADHD clinical trials (e.g., [26, 27]). 
Internationally, this scale has been shown to have accept-
able psychometric properties [25]. It is comprised of 26 
items where 18 items assess ADHD symptoms (9 inat-
tentive, 9 hyperactive/impulsive) and 8 items assess ODD 
symptoms on a 4-point scale (0 =  not at all, 1 =  just a 
little, 2 = quite a bit, 3 = very much). A total composite 
score is calculated by summing all 18 ADHD items and 
two subscale scores are derived by separately summing 
the 9 inattentive and 9 hyperactive/impulsive items. The 
Clinical Global Impression-Severity (CGI-S) scale also 
served as a measure of ADHD symptom severity [28]. 
The CGI-S is rated on a 7-point scale with the severity of 
illness ranging from 1 (normal) to 7 (amongst the most 
severely ill patients).
Modified Go/No‑Go task
This task is a well-known measure of children’s sustained 
attention and response inhibition ([7, 8, 12, 13, 20, 21, 
29–32]. In this version of the Go/No-Go task, a white 
block appeared inside of a white frame on a black back-
ground. A white block appearing at the top of the frame 
was the “go condition” and a white block appearing at the 
bottom of the frame was the “no-go condition”. Children 
were instructed to click the mouse during “go conditions” 
and to refrain from clicking the mouse during “no-go 
conditions”. The duration of each stimulus presentation 
was 500 ms with an inter-trial interval of 1000 ms. Prior 
to initiating the task, participants were asked if they 
could see the screen clearly and if their answer was in 
the affirmative, they were required to complete a mini-
mum of at least five trials with an accuracy of >90% in 
order for their data to be included. Children were then 
asked to complete two runs that consisted of 28 blocks 
(total blocks = 56; 9 trials per block). The first run had a 
Go/No-Go ratio of 2:7, the second run had a ratio of 7:2. 
The whole task took approximately 12.6 min to complete 
(total Go trials = 252, total No-Go trials = 252).
The performance measures of interest for this task 
included: (i) omission errors (no response given dur-
ing “Go” trials); (ii) commission errors (response given 
during “No-Go” trials), (iii) accuracy (correct response 
across “Go” and “No-Go” trials); (iv) multiple response 
errors (multiple responses given after stimulus presenta-
tion during “Go” trials); (v) reaction time (time it takes to 
provide a response during “Go” trials); and (vi) reaction 
time variability (standard deviation of reaction time).
Measures of movement intensity associated with bodily 
motion
Body movements during a Go/No-Go task were moni-
tored and recorded by a Microsoft Kinect infrared 
motion sensing camera. This camera was placed 150 cm 
from the child at a 45° angle from the line between the 
child and a laptop computer that was used to present the 
Go/No-Go task (Fig.  1). To ensure the quality of sam-
pling, children were restricted to standing in a circle with 
a radius of approximately 25  cm [33]. The Kinect cam-
era is a horizontal bar connected to a small base with a 
motorized pivot and consists of a Red–Green–Blue cam-
era and depth sensor. The camera has a pixel resolution 
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of 640 ×  480 and a frame rate of 30 frames per second 
(FPS). The image depth sensor contains a monochrome 
complementary metal oxide semiconductor (CMOS) 
and an infrared projector, which emits multiple infrared 
rays to form a close-spaced light spot matrix in order to 
determine its distances from multiple reference points of 
a participant’s silhouette. The data from this depth sensor 
were then pre-processed to create a 3-dimensional bit-
map that allowed for the monitoring of pixels by compar-
ing temporally adjacent frames to detect movement and 
extract measures of movement intensity [34].
Procedures
Both phases of this study were approved by an ethics 
review board (Scientific Research Ethics Committee of 
the Institute of Psychology, Chinese Academy of Sciences 
Beijing, P.R. China). Informed consent was obtained from 
parents and all child participants gave informed assent 
prior to initiating any study procedures. For those ADHD 
participants recruited from the IBBS study, best-estimate 
DSM-5 diagnoses were assigned by two experienced psy-
chiatrists following a clinical interview with participants’ 
parents using the Chinese version of the Kiddie Schedule 
for Affective Disorders and Schizophrenia—Present and 
Lifetime Version (K-SADS-PL, [35, 36]). ADHD symp-
tom severity ratings were also provided by two expert 
clinicians as part of the IBBS assessment battery. Once 
study eligibility was confirmed, participants completed a 
Go/No-Go Task while the Microsoft Kinect System mon-
itored and recorded their bodily movements. All study 
procedures for this subset of ADHD participants includ-
ing the collection of movement data occurred during the 
IBBS screening visit. The collection of movement data for 
the remaining ADHD participants took place after their 
diagnoses were confirmed at the outpatient psychiatric 
hospital. Diagnoses were made by two experienced psy-
chiatric clinicians based on a clinical interview with the 
children’s parents, parents’ ratings on a measure assessing 
their children’s emotions and behavior (i.e., Achenbach 
Child Behavior Checklist [16]) and an attention task (i.e., 
Cross-out task [37]). Children from the control group 
participated in study procedures during one visit to their 
school by the research team after written consent/assent 
was given. To confirm the typical development of partici-
pating children, their clinical files containing classroom 
behavior history and routine mental health sessions were 
reviewed by the school psychologist. A brief screening 
interview of DSM-5 diagnoses was also done indepen-
dently by an experienced psychiatrist at the local hospi-
tal to confirm their “healthy control” designation. All the 
movement data were collected in private rooms with the 
curtains drawn to limit distractions and control the envi-
ronment’s light so that the children could see the monitor 
screen clearly.
Preprocessing of Microsoft Kinect data
This study used bitmap source data of participants’ sil-
houettes including depth information from the Micro-
soft Kinect system. The raw silhouette data can be quite 
unstable and inconsistencies can be observed when view-
ing the frames in sequence, as noise fragments can be 
observed bursting across the silhouette even when par-
ticipants are standing completely still. The noise level of 
Microsoft Kinect’s infrared sensor has shown to be corre-
lated with the distance between the sensor and target [38] 
so by keeping this distance constant, one source of noise 
was minimized. To further account for the remaining 
noise, a denoise procedure was used to extract the move-
ment intensity measures. First, a baseline assessment of 
movement was conducted by asking participants to stand 
still for 15 s. As the average noise level across all 60 par-
ticipants was 25 pixels (SD =  3.1) when standing still, a 
scan-line algorithm was used to remove regions of noise 
smaller than 25 pixels from each participant’s recording. 
The Kinect data was then preprocessed by comparing two 
temporally adjacent bitmaps of the silhouette pixel-by-
pixel, to determine if there was a change between the two 
frames (see Additional file  1: Figure S1). Within a given 
time interval, if a particular pixel had different spatial 
coordinate values than the previous frame, the program 
was instructed to mark it as a moved pixel. This yielded 
a movement intensity value across two adjacent frames 
where a greater number of moved pixels was indicative of 
greater intensity in the movement between two frames.
Considering the total pixel count that represented a 
child’s body was continually changing due to movement, 
it was necessary to transform the moved pixel count into 
a converted score by dividing the total moved pixel count 
Fig. 1 Physical layout for the study
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by the total mass of the child’s body (i.e., number of pixels 
representing the child’s silhouette in the current fame).
This converted value of movement intensity was 
recorded for each frame. As this value was time-locked, 
it represented a time domain signal to which a Fourier 
transformation was applied to produce a movement 
intensity distribution (MID). Since the Kinect camera has 
a sampling rate of 30 Hz, the frequency domain resolu-
tion was expected to be half this sampling rate, resulting 
in a 0–15 Hz range. The MID data was then subdivided 
into 15 non-overlapping 1  Hz frequency bands (FB). 
Thus, the following measures were calculated from the 
data captured by the Microsoft Kinect System: a com-
posite measure of total movement intensity (TMI) and 
a movement intensity distribution (MID) across 15 fre-
quency bands (the FB measures).
Data analytic plan
Phase 1
All data analyses were conducted using R programming 
language version 3.0.3. Independent two-tailed t tests 
were conducted to compare the ADHD group and con-
trol group on their performance on the Go/No-Go task 
and on each measure of movement intensity. In order 
to examine the precision with which the Kinect infra-
red motion tracking camera differentiated children with 
ADHD from healthy controls, the area under the ROC 
(Receiver Operating Characteristic) curve (AUC) for the 
total movement intensity (TMI) and 15 frequency band 
(FB) measures was calculated. As defined in the research 
literature, an AUC between 0.7 and 0.9 has adequate pre-
cision whereas an AUC above 0.9 has good precision [39]. 
As prior studies have evaluated Go/No-Go performance 
measures as potential indicators of ADHD (e.g., [6], 
ROC-AUC analyses were performed for these measures 
as well. Finally, bivariate correlations were conducted to 
examine associations between measures of movement 
intensity and Go/No-Go task performance.
Phase 2
To further examine the usefulness of the movement 
intensity measures as potential biomarkers for ADHD, 
bivariate correlations were run between the movement 
intensity measures and ADHD symptom severity (e.g., 
ADHD-RS, CGI-S). Correlations between Go/No-Go 
task performance measures and ADHD symptom sever-
ity were also performed. Finally, in an exploratory anal-
ysis, we examined if the same FBs that were associated 
with the ADHD symptom severity measures were also 
correlated with the inattentive and hyperactive-impulsive 
subscale scores of the ADHD-RS. To address the multi-
ple comparison problem, the false discovery rate (FDR) 
method was applied to all p values resulting from tests of 
group differences and correlational analyses.
Results
Phase 1
Children in the control group had significantly better per-
formance across all six performance measures on the Go/
No-Go task as compared to the ADHD group (Table 1). 
The ADHD group displayed more movement than the 
control group, as group comparisons were all statisti-
cally significant (p < 0.05) for the TMI and FB measures 
even after applying the FDR adjustment. The AUC was 
0.904 for the TMI measure and between 0.867 and 0.932 
for the 15 FB measures indicating that these measures of 
movement intensity had adequate to good precision with 
regard to accurately classifying children with and without 
ADHD (Fig.  2). Overall, 29 of 30 children with ADHD 
were discriminated from 25 of 30 normal controls with a 
sensitivity of 0.967 and specificity of 0.833, as calculated 
using the TMI measure. The ROC-AUC analysis for Go/
No-Go task measures revealed AUC values between 0.69 
and 0.93 with reaction time variability having the best 
discriminability: AUC of 0.93, sensitivity of 0.967, and 
specificity of 0.867. Only commission errors on the Go/
No-Go task were significantly correlated with the TMI 
measure (r = 0.28, p = 0.03).
Phase 2
After applying the FDR adjustment, 12 out of 15 fre-
quency bands were correlated with the CGI-S scores and 
10 out of 15 bands were correlated with the ADHD-RS 
total scores, 10 out of 15 bands were correlated with the 
ADHD-RS hyperactivity subscale and 7 out of 15 bands 
were correlated with the ADHD-RS inattentive sub-
scale. The 10–11 and 12–13  Hz frequency bands had 
the strongest correlations with the ADHD-RS (total and 
subscales) and CGI-S scores (Table  2). The TMI meas-
ure was not correlated with the ADHD-RS total scores 
or either the hyperactivity or inattentive subscale scores, 
but it was significantly correlated with the CGI-S scores 
(r = 0.61, p = 0.021). There were no significant correla-
tions between any of the Go/No-Go performance meas-
ures and ADHD symptom severity measures [ADHD-RS 
(total and subscales) and CGI-S].
Discussion
The purpose of this study was to use an infrared motion 
tracking system to monitor and record the movement 
intensity of children in order to determine its diagnos-
tic precision for ADHD and its possible association with 
ratings of ADHD symptom severity. Results from this 
study revealed that our measures of movement intensity 
[i.e., a composite measure of total movement intensity 
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(TMI measure) and a movement intensity distribution 
measure across 15 frequency bands (FB measures)] were 
able to distinguish children with ADHD from healthy 
controls. However, only the measures linked to the 15 
pre-determined 1 Hz frequency bands were significantly 
correlated with both the CGI scores and ADHD-RS 
total scores. The 10–11 and 12–13  Hz frequency bands 
had the strongest correlations with these ADHD symp-
tom severity measures. Both of these frequency bands 
were also significantly associated with the inattentive 
and hyperactive/impulsive subscales of the ADHD-RS. 
The following discussion considers potential implications 
for these findings, limitations of this study’s design, and 
future research directions.
The first phase of this study examined the discrimi-
nating capabilities of our movement intensity measures 
with respect to children with ADHD and healthy con-
trol children. Our results aligned well with prior studies 
using other measures extracted from movement data, as 
children with ADHD performed less well and engaged 
in more movement than healthy control children when 
completing a neuropsychological task of attention and 
response inhibition while their body movements were 
recorded [20, 29]. In contrast to our predictions, our 
movement intensity measures did not outperform, but 
instead, were comparable in terms of their ability to dif-
ferentiate children with ADHD from healthy controls [6, 
12, 19]. Interestingly, the only Go/No-Go performance 
measure to match the discriminating capabilities of our 
movement intensity measures was reaction time vari-
ability, which has been identified as a stable feature of 
ADHD in a recent meta-analytic review [40]. However, 
the only Go/No-Go performance measure to significantly 
correlate with our measures of movement intensity was 
commission errors, which suggests that our findings 
(e.g., correlations between movement intensity measures 
and ADHD symptom severity ratings) are not attribut-
able to the Go/No-Go task and these performance and 
movement intensity measures are potentially tapping dif-
ferent aspects of ADHD.
It is also worth noting that the measure of movement 
intensity used in this study achieved a better classifica-
tion accuracy than did a functional neuroimaging proce-
dure using functional near-infrared spectroscopy (fNIRS) 
during the course of a Go/No-Go task [41]. This suggests 
that the movement intensity procedures used in this 
study might be an effective biomarker for children with 
ADHD at the individual level. More specifically, we are 
interested in determining whether measures of move-
ment may contribute to a clinician’s ability to diagnose, 
evaluate, and monitor a disease, as well as track an indi-
vidual’s response to treatment [22, 23].
The second phase of this study was aimed to further 
examine the usefulness of measures of movement inten-
sity as potential biomarkers for ADHD by looking at 
associations between these movement intensity meas-
ures and ADHD symptom severity. As predicted, our 
measures of movement intensity were significantly cor-
related with overall ADHD symptom severity in addition 
to symptoms of hyperactivity/impulsivity and inatten-
tion whereas movement measures isolated to one loca-
tion of the body are not [12]. Indeed, a more stringent 
test to evaluate the potential of our movement intensity 
measures as ADHD biomarkers was employed since cli-
nician-rated measures of ADHD symptom severity were 
used, which are considered more objective than parent 
or teacher ratings. In contrast, the Go/No-Go perfor-
mance measures failed to significantly correlate with any 
measures of ADHD symptom severity. These findings 
underscore the potential value of monitoring movement 
intensity associated with body movements, over and 
above neuropsychological tasks of attention and response 
inhibition, to objectively assess ADHD symptom sever-
ity over time and in response to treatment. However, 
our results need to be replicated by comparing the dis-
criminating capabilities of the movement intensity meas-
ures to other neuropsychological tasks (e.g., continuous 
Table 1 Go/No-Go task performance measures: ADHD group vs. control group
SD standard deviation; df degree of freedom; AUC area under the curve (an AUC between 0.7 and 0.9 has adequate precision whereas an AUC above 0.9 has good 
precision)
Go/No-Go task
measures
ADHD group (n = 30)
Mean (SD)
Control group (n = 30)
Mean (SD)
t (df) p value AUC
Omission errors 91.0 (38.9) 63.2 (20.1) 3.47 (43.5) 0.001 0.74
Commission errors 61.4 (16.9) 47.1 (14.2) 3.54 (56.4) <0.001 0.76
Accuracy 312.6 (63.0) 366.7 (34.9) −4.12 (45.3) <0.001 0.844
Multiple responses 39.0 (24.0) 26.9 (8.2) 2.62 (35.7) 0.013 0.69
Reaction time (RT) 580.7 (140.2) 428.1 (37.5) 5.76 (33.1) <0.001 0.83
RT variability 269.0 (100.1) 100.2 (34.7) 8.73 (35.9) <0.001 0.929
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performance task) before any firm conclusions can be 
made.
Another novel approach used in this study concerns 
the potential value of movement intensity measures that 
are linked to specific frequency bands. Our preliminary 
data indicate that the 10–11 and 12–13  Hz frequency 
bands are particularly promising. One possible expla-
nation for the strong correlations found between these 
specific frequency bands and clinician ratings of ADHD 
symptoms is that the high frequency signals, after Fou-
rier transformation, reflect minor waves of movement 
intensity that are associated with small movements like 
fidgeting actions of the fingers or partial body discordant 
movements. Such a possibility highlights the sensitivity 
of this particular measure and its potential clinical utility.
Another finding that deserves some attention is that 
the total movement intensity measure did not correlate 
with most measures of ADHD symptom severity. A pos-
sible explanation for this finding could be that the body 
movements associated with ADHD were only reflected in 
a portion of the frequency bands and the total movement 
intensity is the sum of all frequency bands. This also 
provides preliminary support that a frequency domain 
perspective may be a more refined approach to monitor 
ADHD-related body movements.
Future directions and limitations
ADHD is frequently comorbid with other neurode-
velopmental and neuropsychiatric disorders including 
oppositional defiant disorder, conduct disorder, Tourette 
syndrome, depression, anxiety disorder, and learning 
disorders [42]. Future studies are needed to determine 
the degree to which these co-occurring disorders have 
an impact on estimates of movement intensity. This 
may be particularly problematic for movement disor-
ders like Tourette’s Disorder which is highly comorbid 
with ADHD [43]. Given Tourette’s Disorder is a move-
ment disorder, it would be difficult to partition out which 
movements are attributable to Tourette’s and which 
are attributable to ADHD using the current methods 
described in this study. However, applying more mor-
phologic and pattern recognition methods to movement 
data of children with ADHD and Tourette’s may poten-
tially enable us to identify their distinct attributes or even 
build computer vision classifiers. Relatedly, it would be 
worthwhile to use infrared motion tracking technology to 
identify movement patterns of other mental disorders in 
order to isolate those patterns that are specific to ADHD. 
Similar approaches are underway with fNIRS as well 
as volumetric and functional MRI data from individu-
als with a range of neuropsychiatric disorders including 
ADHD [41, 44, 45].
In this study, we recruited participants with ADHD 
across all diagnostic presentations. However, we did 
not compare differences in movement intensity across 
presentations because of our limited sample size. 
Future research should consider determining whether 
or not our movement intensity measures are capable of 
Fig. 2 Phase 1: a Area under the curve (AUC) of the approximate 
total movement intensity; b AUC of the movement intensity distribu-
tion (MID) data for the 10–11 Hz frequency band; and c AUC of the 
MID for the 12–13 Hz frequency band
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differentiating children across ADHD presentations. 
Longitudinal studies are also needed to examine the test–
retest reliability of these measurements as well as their 
ability to monitor symptom severity over time. Indeed, a 
key question concerns the sensitivity of this measure to 
detect clinical improvement following treatment. Assess-
ing simultaneously measures of movement intensity and 
fNIRS in regions identified in the right prefrontal cortex 
during a Go/No-Go task, as was done in a previous study, 
might be another promising line of research [41].
With respect to study limitations, we compared our 
movement intensity measures to a multi-method clini-
cian-driven method of diagnostic classification, which is 
an approach commonly used in clinical trials [7, 18, 46]; 
however, it is important to point out that this is not con-
sidered the “gold standard” of ADHD assessment. There-
fore, future studies should consider comparing these 
measures of movement intensity to this “gold standard” 
(e.g., multi-informant, multi-method evaluation of func-
tioning across multiple settings) to further evaluate its 
diagnostic precision. It should also be noted that our Go/
No-Go task had an equivalent number of Go and No-Go 
trials across the entirety of the paradigm; however, the Go 
trials were five times more frequent than the No-Go tri-
als in the second run of the task, thus capturing response 
inhibition. In future studies, it is recommended that the 
number of Go trials always exceed the number of No-Go 
trials in order to optimize response inhibition. Finally, as 
with all methods of assessment, our measures of move-
ment intensity are not without error. Data quality was 
limited due to the noise of the image signal and a sparse 
light structure sampling coverage with a frame rate of 
30  Hz, thus limiting granularity of the data. Also, the 
frame-to-frame comparison algorithm may have under-
estimated movement for the x–y coordinate axes and 
overestimated for the z-coordinate axis. By using a more 
precise data collection device (e.g. laser scanner) and sur-
face and voxel-based rebuild tracking techniques, there 
may be considerable precision improvement. It may also 
be useful to simultaneously record body movements of 
participants with a visible light band camera to further 
assess the nature of their movements via qualitative analy-
sis software.
Conclusion
Locomotor activity and movement intensity are emerg-
ing as core constructs in our understanding of ADHD. 
In this study, movement intensity measures extracted 
from body movement data by an infrared motion-sens-
ing camera during a Go/No-Go task was found to dis-
tinguish children with ADHD from typically developing 
children and to be highly correlated with clinician rat-
ings of symptom severity. These results suggest that using 
infrared motion detecting systems to calculate measures 
of movement intensity has the potential to become a use-
ful clinical tool that may have several advantages over 
traditional approaches. Specifically, these methods have 
the potential to be more time and cost efficient than the 
“gold standard” of ADHD assessment, thus enhancing 
the likelihood of clinicians making use of this objective 
indicator without relying on single informant measures 
that are subject to biases. These advantages highlight the 
importance of replication studies, as movement intensity 
measures extracted from body movements may prove to 
be a new behavioral biomarker of ADHD.
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